药理学简要指南2025/26:介绍和其他蛋白质标
Stephen P H Alexander1, Alasdair J Gibb2, Eamonn Kelly3
1Division of Physiology, Pharmacology & Neuroscience, School of Life Sciences, University of Nottingham Medical School, Nottingham, NG7 2UH, UK.
药理学简要指南2025/26提供了对人类药物点及其相互作用的全面但易于访问的概述. 这本两年一次的出版物提供专家策划的药理学工具和药物发现命名法.
科学领域:
- 药理学 药理学是指药理学的学科.
- 药物发现 药物发现 药物发现
- 生物化学 生物化学
背景情况:
- 英国药理学杂志每两年发表一次"药理学简要指南"的更新.
- 该指南提供了对药物目标家庭的比较概述.
- 2025/26年版是本系列的第七期.
研究的目的:
- 提供对人类药物点及其相互作用的清晰,易于访问和结构良好的摘要.
- 提供专家策划的选择性药理学工具的建议,以确定目标.
- 作为药理信息的永久,可引用,及时记录.
主要方法:
- 大约1900个人类药物点的关键药理性质的总结.
- 将近7000个相互作用包括在内,涉及约4400个连接体.
- 专注于六个关键领域:G蛋白结合受体,离子通道,核激素受体,催化受体,酶和输送器.
主要成果:
- 该指南详细介绍了大约1900种人类药物标和7000种相互作用的药理学.
- 它提供了IUPHAR (基础和临床药理学国际联盟) 的官方分类和命名,如适用.
- 包括专家策划的"黄金标准"选择性药理学工具的建议.
结论:
- 药理学简要指南2025/26为研究人员提供了有价值,稳定的参考资料.
- 它通过提供可引用的当前知识快照来补充在线药理学指南网站.
- 该指南通过提供关于药物标和药理工具的精心策划的信息来促进药物发现.
更多相关视频
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
05:28A Semi-Quantitative Drug Affinity Responsive Target Stability DARTS assay for studying Rapamycin/mTOR interaction
Published on: August 27, 2019
相关概念视频
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Pharmacodynamics: Overview and Principles
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
Nonlinear Pharmacokinetics: Bioavailability and Protein-Drug Binding
To quantify the extent of bioavailability, pharmacologists often use a parameter called .
Principles of Drug Action
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Physiological Pharmacokinetic Models: Assumption with Protein Binding
Protein-Drug Binding: Mechanism and Kinetics
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
